-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $115

Benzinga·11/05/2026 09:55:02
BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $115.